Fiona Rutherford
-
Psychedelic Drug Maker Cuts 75% Of Staff After FDA Rejects MDMA
The company said it will leave only a small team focussed on reversing the Food and Drug Administration’s decision.
-
FDA Tests New Power to Pull Some Fast-Tracked Drugs Off Market
Its first target is a cancer treatment from Oncopeptides given accelerated approval in 2021, which has since faced a study questioning its effectiveness.
-
FDA Raises Issues With Nonprescription Birth Control Pill
Opill may not be effective as a nonprescription pill given Americans’ increasing body weight, regulators said.
-
FDA Raises Issues With Nonprescription Birth Control Pill
Opill may not be effective as a nonprescription pill given Americans’ increasing body weight, regulators said.
-
FDA Lays Out Annual Covid Shot Plan Similar To Flu
US drug regulators are setting out a plan for updating Covid-19 vaccines similar to the one in place for flu that will include at least annual reviews of new strains to be targeted by shots.
-
CVS, Walmart, Walgreens Reach $13 Billion Opioid Settlement
The accords won’t be finalized until enough states, counties and cities agree to them, the people said.
-
Pfizer to Test Second Paxlovid Course in Patients With Covid Rebound
Pfizer Inc. was ordered by US regulators to test the effects of an additional course of Paxlovid among people who experience a rebound in Covid-19 after treatment, putting the drug through further study as reports of the mysterious phenomenon continue to mount.
-
Monkeypox Risk Is Low, Vaccines Ready If Needed, U.S. Says
U.S. officials sought to reassure the public that the risk of monkeypox is low and the country is prepared to handle its spread.
-
Walgreens Settles Florida Opioid Sales Suit for $683 Million
Walgreens Settles Florida Opioid Sales Suit for $683 Million
-
Women Scramble to Get IUDs, Load Up on Plan B as Roe Worries Hit
Women Scramble to Get IUDs, Load Up on Plan B as Roe Worries Hit
-
Pfizer’s Covid Pill Will Soon Be Available Across the U.S.
Pfizer's Covid Pill Will Soon Be Available Across the U.S.
-
Most People Under 50 Don’t Need 4th Shot Yet, CDC Panel Suggests
People with comorbidities should consider an extra shot, but most people should hold out for better vaccines later this year.
-
U.S. Stops Mask Requirement on Planes After Judge’s Ruling
Mask Mandate for Planes, Trains Overturned by Federal Judge
-
CDC Advisors to Discuss Booster Plans at Wednesday Meeting
Mystery CDC Meeting May Set Tone for Next Booster Campaign
-
Are Second Covid Booster Shots Effective? What Experts Know So Far
Are Second Covid Booster Shots Effective? What Experts Know So Far
